BWXT

BWX Technologies is rated Buy, leveraging its leadership in U.S. naval nuclear components and emerging commercial and military reactor opportunities. BWXT's recent underperformance and multiple compression have brought shares near Base case fair value, with a Bull case offering 32% upside. Key growth drivers include U.S. Navy procurement, data center nuclear fuel partnerships, and military microreactor projects, but risks stem from customer concentration and competitive threats.

During Q3 2026, the Polen 5Perspectives Small-Mid Growth Composite Portfolio returned -12.5% (net of fees) compared to the -10.4% return of the Russell 2500 Growth Index. The top contributors to the Portfolio's relative performance in the quarter were Twist Bioscience, Twilio, and Embraer. The most significant detractors from the Portfolio's relative performance in the quarter were nLight, Terawulf, and BWX Technologies.

BWX Technologies' nuclear growth, $1.4 billion in naval contracts and raised 2026 guidance bolster its outlook, but valuation, margin pressure and execution risks warrant caution.

BWX Technologies' 19.8% stock decline offers a more attractive entry point as nuclear demand and backlog grow, but valuation, margin pressure and execution risks warrant caution.

BWX Technologies raises its 2026 revenue, earnings and cash flow guidance as commercial nuclear growth surges, but margin pressure and fourth-quarter execution pose risks.

BWX Technologies (BWXT) is upgraded to Buy, with a YE27 price target of $183, offering 25% upside after a valuation reset. BWXT's core defense business provides stable, predictable cash flows, while commercial nuclear operations drive accelerating growth and margin expansion. Commercial segment revenue grew 63% in 2025 and is guided up 45% in 2026, with high-teens CAGR and EBITDA margin expansion targeted through 2030.

BWXT is expanding specialized uranium processing capabilities, supporting government nuclear programs through recovery, purification and downblending operations.

TORONTO--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) announced today that Prodigy Clean Energy, Ltd., Pabineau First Nation and Eel River Bar First Nation have selected its BANR microreactor technology for a Transportable Nuclear Power Plant (TNPP) to be located in Belledune, New Brunswick. Prodigy announced last month the Indigenous-led nuclear new build proposal in Belledune, which would feature an up to 50 megawatts electric full-scale Prodigy TNPP within the traditional territory o.

BWX Technologies is rated Buy at $135, with valuation justified by robust growth in commercial nuclear and special materials segments. BWXT's backlog has more than doubled to $8.4 billion, with commercial operations expected to deliver high-teen revenue CAGR and EBITDA growth above 20% through 2030. Execution risk remains the primary concern, as significant profit acceleration hinges on timely delivery of new plants and contracts in commercial nuclear and special materials.

BWX Technologies is the exclusive manufacturer of nuclear reactors and fuel for the U.S. Navy. The company is expanding across commercial nuclear power, small modular reactors, microreactors, and advanced nuclear fuels.